RIVERSIDE REGIONAL MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.5M
- Transactions
- 824
- Companies
- 40
- Average per transaction
- $1,822
Who reported the payments
| Roche Products Limited | $168,479 |
| American Regent | $134,931 |
| Novartis | $127,773 |
| Adamas Pharmaceuticals, Inc. | $116,767 |
| Janssen Research & Development, LLC | $97,004 |
| Insulet Corporation | $88,150 |
| Boston Scientific | $85,684 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $81,326 |
| Eisai Inc. | $75,166 |
| Boehringer Ingelheim International GmbH | $65,355 |
| Biogen | $60,746 |
| Stryker | $33,767 |
| Alkermes, Inc. | $29,125 |
| Pfizer | $29,000 |
| Sanofi | $26,700 |
| Acell, Inc. | $25,835 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $19,707 |
| GW Research Limited | $18,931 |
| Sage Therapeutics, LLC | $18,805 |
| AstraZeneca | $16,500 |
| Tandem Diabetes Care, Inc. | $16,250 |
| Penumbra, Inc. | $15,925 |
| Vapotherm Inc | $15,878 |
| Hill-rom Company, Inc | $14,786 |
| Linvatec Corporation | $11,219 |
| Abbott | $8,438 |
| Taiho Oncology, Inc. | $7,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | $6,500 |
| Genentech USA, Inc. | $6,000 |
| Bioventus LLC | $5,451 |
| Agfa Healthcare Corporation | $5,430 |
| Chiesi USA, Inc. | $4,260 |
| Merck | $4,000 |
| Astellas Pharma US Inc | $4,000 |
| Philips North America LLC | $3,595 |
| Jazz Pharmaceuticals Inc. | $3,500 |
| AbbVie | $3,250 |
| E.r. Squibb & Sons, L.L.C. | $3,000 |
| Beone Medicines USA, Inc. | $3,000 |
| Biosense Webster, Inc. | $2,900 |